<DOC>
	<DOCNO>NCT02843828</DOCNO>
	<brief_summary>The purpose study investigate effect new wearable hip assist robot develop Samsung Advanced Institute Technology ( Samsung Electronics Co , Ltd. , Korea ) gait rehabilitation elderly adult stroke patient .</brief_summary>
	<brief_title>Gait Pattern Analysis Feasibility Gait Training With Walking Assist Robot Stroke Patients Elderly Adults</brief_title>
	<detailed_description>Randomized , two treatment group Number Subjects : 54 subject ( n=27 per group ) Group 1 : gait rehabilitation hip assist robot / 10 session ( 5sessions - treadmill gait train / 5sessions - overground gait training ) , 30min per session Group 2 : gait rehabilitation without hip assist robot / 10 session ( 5sessions - treadmill gait train / 5sessions - overground gait training ) , 30min per session Primary objective demonstrate effect hip assist robot spatio-temporal parameter measure motion capture system ( Motion Analysis Corporation , Santa Rosa , CA , USA ) , muscle activation pattern measure surface electromyography ( sEMG ) ( Noraxon Inc. , Scottsdale , AZ , USA ) , metabolic energy cost parameter measure portable cardiopulmonary metabolic system ( Cosmed K4B2 , Rome , Italy ) foot pressure distribution measure F-Scan Mobile system ( Tekscan Inc. , South Boston , MA , USA ) . Secondary objective demonstrate effect hip assist robot motor function improvement evaluate Berg Balance Scale ( BBS ) , Tinetti performance orient mobility assessment ( POMA ) , Korean version Modified Bathel index ( K-MBI ) , Modified Rankin Scale ( MRS ) , Functional Ambulation Classification ( FAC ) , Fugl-Meyer assessment low extremity ( FMA ) , Korean version Fall Efficacy Scale ( K-FES ) , Manual Muscle Test ( MMT ) Range Motion ( ROM ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Elderly adult 1 . Age : 65 84 year 2. elderly adult neurological musculoskeletal abnormality affect gait 3 . Ability walk least 10m regardless assist device 4 . High level physical performance ( SPPB &gt; 7 ) 5 . Subject willing randomize control group treatment group Stroke 1 . Age : 50 84 year 2 . â‰¥ 3 month post stroke 3 . Ability walk least 10m regardless assist device 4 . Adequate gait function ( FAC &gt; 3 ) 5 . Physician approval patient participation 6 . Subject willing randomize control group treatment group Elderly adults 1 . History disease ( eg . low extremity orthopedic disease , neurologic disorder , cardiovascular disease , heart failure , uncontrolled hypertension affect walk capacity , efficiency , endurance ) 2 . Severe visual impairment dizziness increase risk fall Stroke 1 . Serious cardiac condition ( hospitalization myocardial infarction heart surgery within 3 month , history congestive heart failure , document serious unstable cardiac arrhythmia , hypertrophic cardiomyopathy , severe aortic stenosis , angina dyspnea rest activity daily live ) 2 . Advanced liver , kidney , cardiac , pulmonary disease 3 . History concussion last 6 month 4 . History unexplained , recur headache , epilepsy/seizures/skull fracture skull deficit 5 . Preexisting neurological disorder Parkinson 's disease , Amyotrophic Lateral Sclerosis ( ALS ) , Multiple Sclerosis ( MS ) , dementia</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Exoskeleton Device</keyword>
	<keyword>elderly</keyword>
	<keyword>stroke</keyword>
	<keyword>gait rehabilitation</keyword>
</DOC>